VMD

Viemed Healthcare Inc. Common Shares (VMD)

Stock · NASDAQ · Health Care

$9.49as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

VMD adopts automatic securities disposition plan. Viemed Healthcare announced that President Michael Moore has adopted an automatic securities disposition plan. The plan will automatically handle the company's share transactions according to a set schedule. This corporate step could affect the number of shares outstanding and may be reflected in market activity, while the stock is currently near its $9.52 support level.

Active signals

Support level
$8.67
Industry
Misc Health and Biotechnology Services

What VMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike39+1.8%62%
Bollinger Band Breakout24+2.9%63%
Bollinger Band Breakdown19+2.2%53%
200-Day Moving Average TouchActive now130.0%46%
Any 20-session window (baseline)+1.0%53%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About VMD

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and relat…

Sector
Health Care
Industry
Misc Health and Biotechnology Services
Employees
1,438

Fundamentals

1-day range
$9.42$9.83
Market cap
$362.60M
P/E (trailing)
25.72
P/E (forward)
23.70
EPS (trailing)
$0.36
Dividend yield
—
Beta
1.05
Avg. volume
343.3K
52-week range
$6.05$12.61
Next earnings: November 4, 2026 · EPS estimate $0.12confirmed

How Viemed Healthcare Inc. Common Shares Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$270.28MNet Income$14.93M (6%)SG&A$121.37M (45%)Cost of Revenue$114.82M (42%)Other$9.75M (4%)Tax$6.39M (2%)R&D$3.02M (1%)VMD

Source: 10-K filed Mar 4, 2026 · via SEC EDGAR / Finnhub

Gross Profit$155.46M(58%)
Operating Income$22.95M(8%)

Forecasts

2 analyst ratings

Buy 71%
Hold 29%
Sell 0%
1-year price forecast
High
$14
+47.5%
Median
$12.5
+31.7%
Low
$11
+15.9%

Viemed Healthcare Inc. Common Shares Competitors

Chosen by industry and closest market cap.

  • VMD
    Viemed Healthcare Inc. Common Shares
    $9.48
    ▼ 2.77%
    Market cap $362.60MP/E 25.72
    $6.05$12.61
  • PARK
    Park Dental Partners Inc. Common Stock
    $18.95
    ▼ 1.33%
    Market cap $96.71MP/E —
    $9.53$26.79
  • CCEL
    Cryo-Cell International Inc. Common Stock
    $4.42
    ▲ 21.10%
    Market cap $28.78MP/E —
    $2.72$4.9
  • MGRX
    Mangoceuticals Inc. Common Stock
    $0.29
    ▼ 9.66%
    Market cap $10.31MP/E —
    $0.162$2.75
  • NIVF
    NewGenIvf Group Limited Class A Ordinary Shares
    $0.279
    ▲ 11.60%
    Market cap $3.36MP/E 0.18
    $0.1722$24,624
  • NIVFW
    NewGenIvf Group Limited Warrants
    $0.0123
    ▼ 11.51%
    Market cap $102.7KP/E —
    $0.0086$0.09
  • AGL
    agilon health inc. Common Stock
    $85.12
    ▼ 3.76%
    Market cap $1.45BP/E —
    $7.48$133.04

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
123.0K
Disposed
11.7K

Institutional Ownership

March 31, 2026

Total shares held
24.26M
Total value held
$218.77M
Institutional holders
143
Top holders this quarter
  • Unknown4.62M
  • Unknown2.83M
  • Unknown1.42M
  • Unknown1.30M
  • Unknown898.3K
  • Unknown883.8K
  • Unknown779.5K
  • Unknown743.0K
  • Unknown711.2K
  • Unknown537.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.